Excess Copper Chelating Therapy for Wilson Disease Induces Anemia and Liver Dysfunction

被引:11
|
作者
Harada, Masaru [1 ]
Miyagawa, Koichiro [1 ]
Honma, Yuichi [1 ]
Hiura, Masaaki [1 ]
Shibata, Michihiko [1 ]
Matsuhashi, Toru [1 ]
Abe, Shintaro [1 ]
Harada, Riko [1 ]
Tabaru, Akinari [1 ]
机构
[1] Univ Occupat & Environm Hlth, Japan Sch Med, Dept Internal Med 3, Tokyo, Japan
关键词
ceruloplasmin; chelating therapy; hemochromatosis; Wilson disease; ACQUIRED SIDEROBLASTIC ANEMIA; LATE ENDOSOMES; IRON; GENE; CERULOPLASMIN; ATP7B; ACERULOPLASMINEMIA; FERROPORTIN; DIAGNOSIS; HEPCIDIN;
D O I
10.2169/internalmedicine.50.5209
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 37-year-old man was diagnosed with Wilson disease at the age of 14. His first manifestations were neurological. He was treated with trientine for more than 10 years and suffered from anemia and liver dysfunction. Wilson disease is a genetic disorder characterized by accumulation of copper in the body. Excess copper is toxic, but copper is an essential trace element. Copper-binding ceruloplasmin is important for iron metabolism. Excess copper chelating treatment-induced anemia and iron deposition in the liver was suspected. Proper monitoring of copper status is important for the management of Wilson disease.
引用
收藏
页码:1461 / 1464
页数:4
相关论文
共 45 条
  • [11] A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson Disease
    Greig, Jenny A.
    Nordin, Jayme M. L.
    Smith, Melanie K.
    Ashley, Scott N.
    Draper, Christine
    Zhu, Yanqing
    Bell, Peter
    Buza, Elizabeth L.
    Wilson, James M.
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2019, 30 (01) : 29 - 39
  • [12] Cardiac arrest in Wilson's disease after curative liver transplantation: a life-threatening complication of myocardial copper excess?
    Bobbio, Emanuele
    Forsgard, Niklas
    Oldfors, Anders
    Szamlewski, Piotr
    Bollano, Entela
    Andersson, Bert
    Lingbrant, Marie
    Bergh, Niklas
    Karason, Kristjan
    Polte, Christian L.
    ESC HEART FAILURE, 2019, 6 (01): : 228 - 231
  • [13] Effect of chelation therapy in pediatric Wilson's disease: Liver and endoscopic outcome
    Das, Mridul Chandra
    Sen Sarma, Moinak
    Srivastava, Anshu
    Yachha, Surender Kumar
    Poddar, Ujjal
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2021, 28 (04) : 336 - 345
  • [14] Plasma exchange and chelator therapy rescues acute liver failure in Wilson disease without liver transplantation
    Kido, Jun
    Matsumoto, Shirou
    Momosaki, Ken
    Sakamoto, Rieko
    Mitsubuchi, Hiroshi
    Inomata, Yukihiro
    Endo, Fumio
    Nakamura, Kimitoshi
    HEPATOLOGY RESEARCH, 2017, 47 (04) : 359 - 363
  • [15] Liver pathology in Wilson's disease: From copper overload to cirrhosis
    Gerosa, C.
    Fanni, D.
    Congiu, T.
    Piras, M.
    Cau, F.
    Moi, M.
    Faa, G.
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2019, 193 : 106 - 111
  • [16] Symptom aggravation after withdrawal of metal chelating agent therapy in patients with Wilson's disease
    Zhou, Xiangxue
    Liao, Jian
    Liu, Yinjie
    Qin, Haolin
    Xiao, Xia
    BRAIN AND BEHAVIOR, 2023, 13 (09):
  • [17] Wilson disease: copper deficiency and iatrogenic neurological complications with zinc therapy
    Wu, Landy M.
    Ekladious, Adel
    Wheeler, Luke
    Mohamad, Abdulrazak A.
    INTERNAL MEDICINE JOURNAL, 2020, 50 (01) : 121 - 123
  • [18] Cutting edge: ferroptosis in metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis and therapy
    El-Sehrawy, Amr Ali Mohamed Abdelgawwad
    Rashid, Teeba Ammar
    Ullah, Muhammad Ikram
    Uthirapathy, Subasini
    Ganesan, Subbulakshmi
    Singh, Abhayveer
    Devi, Anita
    Joshi, Kamal Kant
    Jasim, Ahmed Salman
    Kadhim, Abed J.
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2025, 25 (01)
  • [19] Hepatocyte-specific localization and copper-dependent trafficking of the Wilson's disease protein in the liver
    Schaefer, M
    Hopkins, RG
    Failla, ML
    Gitlin, JD
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1999, 276 (03): : G639 - G646
  • [20] Biological regulation of copper and selective removal of copper: Therapy for Wilson disease and its molecular mechanism
    Suzuki, KT
    Ogura, Y
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2000, 120 (10): : 899 - 908